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Introduction
Many acquired and inherited diseases which affect the lympho-hematopoietic system could be treated effectively by repopulation with genetically modified, autologous stem cells that results in consistent expression of the transferred gene in differentiating hematopoietic cells. 1 Clinical protocols have been developed for evaluation of gene therapy approaches for severe combined immune deficiency due to adenosine deaminase deficiency, Gaucher's disease, chronic granulomatous disease and acquired immunodeficiency syndrome. 1 Substantial effort has also been invested into the development of gene therapy strategies for the hemoglobin disorders, severe ␤-thalassemia and sickle cell anemia. Progress has been limited by the relative inefficiency of the available methods for gene transfer into the quiescent stem cell population. 1 Current attempts to employ stem cell targeted gene transfer for the treatment of human diseases originated with the demonstration that retroviral vectors based on murine leukemia viruses (MuLV) could be used to achieve gene transfer and integration into stem cells of mice. 2, 3 This methodology has subsequently been refined so that efficient gene transfer into stem cells and longterm expression of the transferred gene in maturing hematopoietic cells can now readily be achieved in murine models. 4 However, attempts to apply this methodology for stem cell targeted gene transfer in large animal models 5, 6 and humans 7, 8 have met with very limited success. A significant factor accounting for the relatively higher efficiency of gene transfer in the murine system is the level of expression of the receptor used for vector entry into stem cells. Ecotropic vectors used for gene transfer into mouse stem cells rely on a cationic amino acid transporter for cell entry. 9 The human form of this protein does not support vector uptake. Instead, amphotropic vectors used for primate stem cell gene transfer rely on a phosphate symporter that is expressed at much lower levels in primitive hematopoietic cells. 10 These differences in the level of receptor expression correlate with the efficiency of gene transfer into repopulating cells. 10 Other biological and methodological factors may also contribute to the much higher efficiency of gene transfer achieved in the murine system. Gene transfer by MuLV vectors requires cell division; mouse stem cell cycle more frequently than those of humans. 11 Furthermore, routine administration of a myeloablative dose of 5-fluorouracil (5-FU) to mice 48 h before to marrow harvest has been shown to initiate cell cycle progression in the primitive hematopoietic cell population. 12 Differences in the pharmacokinetics of 5-FU and stem cell dynamics have prevented the ready adaption of this strategy in other animal models. The highest levels of gene transfer in the murine system are achieved by co-culture of the target marrow cells with vector producer cells but only the non-adherent subset of repopulating cells, about 25% of the total, are recovered from such co-cultures. 12 In the syngeneic mouse model, more donors can be used to ensure that adequate cells are available for engraftment whereas in larger animals and humans, the number of cells available for ex vivo manipulation and subsequent reconstitution is limited by the number of autologous cells that can be harvested from the recipient.
Several innovative strategies hold promise in overcoming the barriers to therapeutic, stem cell targeted gene transfer. Cytokine mobilized peripheral blood and bone marrow stem cells are more susceptible to MuLV vectormediated gene transfer. 13 Coating of culture plates with a fragment of fibronectin increases gene transfer efficiency by co-localization of target stem cells and vector particles.
14 Culture of stem cells for up to 4 days in serum-free medium containing complex cytokine mixtures which include both stem cell factor and the ligand for Flt3 receptor allows limited stem cell expansion 15 and may result in a significant increase in gene transfer efficiency. However, efforts to overcome the barrier imposed by the low level of expression of the amphotropic receptor by using vectors pseudotyped with the envelope of Gibbon ape leukemia virus (GALV) which rely on a different phosphate symporter for cell entry, have resulted in only a modest improvement in gene transfer efficiency into stem cells in a baboon model. 6 Our work has focused on an alternative approach to solve the problem of receptor expression. We 16 and others [17] [18] [19] have shown that DNA viral vectors such as adenovirus or recombinant adeno-associated virus (rAAV) can be used to achieve functional expression of the murine ecotropic retroviral receptor on human cells thereby rendering those cells susceptible to transduction by ecotropic MuLV vectors. Adenoviral vectors have been shown to transduce primitive human hematopoietic cell populations with relatively high efficiency. [20] [21] [22] [23] Both the CD38 + and CD38 − subsets were transduced as were the subset of CD34 + cells that were demonstrably in the G 0 phase of the cell cycle. 20 Transduction can be achieved without interference with cell proliferation or hematopoietic maturation. 23 In contrast, transduction of primitive hematopoietic cells with rAAV may require very high multiplicities of infection. 24 In addition, transduction efficiency has been reported to vary among individuals 25 perhaps because of variability in the level of expression of heparan sulfate proteoglycan which serves as a receptor for rAAV. 26 Furthermore, rAAV vectors transduce non-cycling cells less effectively than cycling cells. 27 In our studies, adenoviral vectors have been constructed which transferred and expressed the mouse ecotropic retroviral receptor. Functional expression of this receptor allowed permanent integration of a MuLV genome into primitive human hematopoietic cells. Use of an adenoviral vector with a modified fiber protein 28, 29 resulted in a higher efficiency of transfer of the ecotropic retroviral receptor gene. These results support the further development of the adenoviral vector system for overcoming the barrier to stem cell-targeted, retrovirusmediated gene transfer imposed by limited receptor number.
Results
Transient expression of the murine ecotropic receptor facilitates transduction of human hematopoietic cells by ecotropic retrovirus These initial experiments were designed to determine if adenovirus-mediated transient expression of the ecotropic receptor on the surface of human cells would result in the transduction of those cells with an ecotropic retrovirus. HeLa, human erythroleukemia (K562) and myeloid leukemia (KG-1a) cells were exposed to a conventional adenoviral vector encoding the ecotropic retroviral receptor under the control of the RSV promoter (Av1 RSVEcoRec) at various MOIs. Transduction efficiency was determined by assessing the expression of the ecotropic retroviral receptor by florescence activated cell sorting (FACS) analysis 48 h later. HeLa cells were transduced most efficiently in that at an MOI of 10 2 all of the cells were expressing the receptor (Table 1 ). K562 cells required an MOI of 10 3 to obtain expression in 100% of the cells (Figure 1a , panels A-E; Table 1 ) whereas even at an MOI of 10 5 only 18% of the KG-1a cells expressed the receptor (Table 1) .
To establish the relationship between ecotropic receptor expression and transduction by ecotropic retrovirus the Av1 RSV-EcoRec transduced cells were exposed to an ecotropic retroviral vector encoding a C-terminal truncated form of the nerve growth factor receptor (G1-NGFR T ) at an MOI of 5. Retroviral transduction efficiency was assessed 48 h after transduction by determining the cell surface expression of the truncated NGFR using flow cytometry. In all cases (HeLa, K562 and KG-1a cells) the percentage of NGFR T expressing cells increased as a function of the MOI of Av1 RSV-EcoRec (Figure 1a , panels F-J and Table 1 K562 cells that had been exposed to various MOIs of Av1 RSV-EcoRec and subsequently to the ecotropic G1-NGFR T ( Figure 1a ) were expanded. DNA was extracted from these cells, digested with NheI and probed for the presence of the G1-NGFR T genome ( Figure 1b) ; NheI cuts in each LTR releasing an internal proviral genomic fragment. The intensity of the 2.5 kb NheI fragment increased with increasing MOIs of Av1 RSV-EcoRec and correlated with the percentage of cells expressing NGFR T ( Figure  1a , panels F-J compared with Figure 1b ). K562 cells transduced with Av1 RSV-EcoRec at a MOI of 1000 and then with G1-NGFR T were plated in semi-solid medium. After 2 weeks, individual clones were plucked and expanded in liquid medium. DNA was isolated from these clones and similarly analyzed for the presence of the G1-NGFR T genome ( Figure 2c ). Twenty-two of 35 colonies contained at least one copy of the proviral genome ( Figure 2a and data not shown). Therefore, transduction efficiency as determined by DNA analysis was 63% compared with 51% (Table 1) Enhanced transduction of K562 cells with adenoviral vector particles containing a chimeric fiber protein Since adenovirus 3 and 5 serotypes utilize different receptors for cellular attachment, 29 experiments were performed to compare the transduction efficiencies of hematopoietic cells with vectors having these receptor specificities. K562 cells were transduced with Av9 RSVLacZ4, a vector with adenovirus 3 receptor binding speci- ficity, 29 and Av1 RSV-LacZ4, a vector with adenovirus 5 receptor binding specificity. 30 Av9 RSV-LacZ4 differs from Av1 RSV-LacZ4 in that it (Av9 RSV-LacZ4) contains a chimeric fiber gene in which the sequences encoding the fiber head have been replaced with corresponding sequences from an adenovirus 3 serotype virus. Av1 RSV-LacZ4 has the conventional fiber gene encoding a protein of adenovirus 5 serotype. Av9 RSV-LacZ4 was approximately 20-fold more efficient at transducing K562 cells in that the proportion of LacZ-positive cells at an MOI of 50 was approximately the same as that seen with the Av1 RSV-LacZ4 at an MOI of 1000 ( Figure 3 ). Transduction of KG1a cells was also more efficient with Av9 RSV-LacZ4 than with Av1 RSV-LacZ4 (18% versus Ͻ1% LacZ-positive cells, respectively, at an MOI of 10 5 ).
Effect of transgene promoter and adenoviral fiber head on transduction of CD34
+ cells Human CD34
+ cells from cord blood were transduced with Av1 RSV-EcoRec at an MOI of 10 5 and assayed for the presence of the ecotropic receptor on the cell surface ( Figure 4a ); approximately 20% of the cells were positive.
These cells were subsequently transduced with G1-NGFR T ecotropic retrovirus and then plated in semi-solid media. Six colonies of 94 were found to contain G1-NGFR T proviral DNA by PCR analysis (Figure 4b and data not shown). This transduction efficiency is considerably lower than that reported by others 20 using an adenovirus serotype 5 vector encoding the alkaline phosphatase gene under the control of the Moloney murine leukemia virus LTR. The disparity in transduction efficiency may be explained by the different promoters used in these studies. Indeed, a recent study indicates that the RSV promoter is much less efficient at driving transgene expression in primary CD34
+ cell transduced with adenoviral vectors when compared with the CMV E1a promoter. 31 The next set of experiments was, therefore, designed to determine the effect of the CMVE1a promoter on the expression of the adenoviral transgene in cord bloodderived CD34 + cells. Freshly isolated CD34 + cells were transduced at various MOIs with a conventional Ad5 vector (Ad5 CMV-GFP), in which the green fluorescent protein (GFP) gene is under the control of the CMV E1a promoter, followed by FACS analysis 48 h later. As can be seen from Figure 5 , the Ad5 CMV-GFP adenoviral vector was highly efficient at transducing CD34 + cells in a dose-dependent manner ( Figure 5 ). At the highest MOI (10 4 ) 68% ± 8 of CD34
+ cells expressed GFP. These results were reproducible with little cord to cord variation in transduction efficiency. In addition, 24 h of pre-stimulation (analogous to the pre-stimulation used with Av1 RSV-EcoRec transduction protocol) had no effect on the CD34 + cell transduction efficiency of Ad5 CMV-GFP (data not shown).
The effect of the CMVE1a promoter on the expression of the ecotropic receptor in CD34
+ cells was also examined using the conventional adenoviral vector, as well as the vector containing the chimeric fiber protein. Freshly isolated CD34
+ cells were transduced, at various MOIs, with Av1 CMV-EcoRec and Av9 CMV-EcoRec. Transduction of CD34
+ cells with Av1 CMV-EcoRec at an MOI of 10 4 ( Figure 6 ) resulted in 48% of cells expressing the ecotropic receptor, which is twice that observed previously with Av1 RSV-EcoRec at an MOI of 10 5 . Transduction of CD34
+ cells with Av9 CMV-EcoRec leads to further improvement in the transduction efficiency in that a log less viral particles were required to achieve the same level of ecotropic receptor expression as observed with Av1 CMV-EcoRec ( Figure 6 ). The difference in the transduction efficiency of CD34 + cells, between Av1 CMV-EcoRec and Av9 CMV-EcoRec, was consistent and reproducible with CD34
+ cells derived from multiple cord blood samples. However, a small reduction (10-23%) in recovery of the CD34 + cells following exposure to Ad5 CMV- GFP and the Av1 CMV-EcoRec and Av9 CMV-EcoRec adenoviral vectors was observed at an MOI of 10 4 , consistent with the observation of others. [20] [21] [22] [23] Sequential transduction of primary human hematopoietic cells To determine the adenoviral transduction efficiency of hematopoietic precursors, at the progenitor level, CD34 + cells were first transduced with either Av1 CMV-EcoRec or Av9 CMV-EcoRec. After 24 h, the cells were exposed to a bicistronic ecotropic retrovirus, MGirL22Y, at an MOI of 5. This virus contains the GFP and a variant of human dihydrofolate reductase (L22Y) genes under the control of the murine stem cell virus LTR (MSCV). Retroviral transduction efficiency was determined by assessing the number of CD34 + cells expressing GFP by flow cytometry. In addition, the transduction of the clonogenic progenitors was determined by quantifying colony formation in the presence of trimetrexate (TMTX) (150 nm).
There was a direct correlation between MOI of adenoviral vector and subsequent transduction with the ecotropic retrovirus as reflected by the proportion of CD34 + cells that expressed GFP and the number of hematopoietic colonies which were TMTX resistant due to the expression of L22Y (Table 2) . Consistent with the level of ecotropic receptor expression, Av9 CMV-EcoRec transduced cells had a two-fold higher susceptibility to ecotropic retroviral transduction when compared with Av1 CMV-EcoRec transduced cells, based on the number of TMTX-resistant colonies and GFP-positive CD34 + cells. Thus higher ecotropic receptor expression leads to an increased susceptibility of the hematopoietic clonogenic progenitors to ecotropic retroviral transduction. However, the colony-forming potential of CD34
+ cells transduced with adenoviral vectors was variable but somewhat lower, at the higher MOIs, when compared with the mock-transduced cells in which exposure to the adenovirus was omitted. In contrast sequential transduction of CD34
+ cells with lower adenoviral MOI had little effect on hematopoietic colony formation.
The adenoviral vector transduction efficiency of the CD38 − fraction of the CD34 + cell population was also determined. The CD34 + CD38 − subset was isolated from the CD34 + -enriched population by FACS selection as described in Materials and methods. These cells were transduced with either Av1 CMV-EcoRec or Av9 CMVEcoRec at an MOI of 10 4 . After 24 h, the adenovirus-transduced cells were exposed to the ecotropic retrovirus MGirL22Y at an MOI of 5. As with unsorted CD34 + cells, the CD34 +
CD38
− subset was transduced almost twice as efficiently by Av9 CMV-EcoRec than Av1 CMV-EcoRec as determined by the level of ecotropic receptor expression ( Figure 7) . This difference was further translated into higher transduction by the ecotropic retrovirus MGirL22Y as reflected by the number of GFP positive CD34 +
− cells.
Discussion
Our results indicate that sequential transduction with an adenoviral vector expressing a murine ecotropic retroviral receptor followed by transduction with an ecotropic retroviral vector results in stable integration of the retroviral genome into human hematopoietic cell lines and primary clonogenic progenitors. The integration frequency of the retroviral genome, as reflected by the proportion of vector-expressing cells and by the copy number of the proviral genome, increased with increasing expression of the ecotropic retroviral receptor which in turn was directly correlated with the multiplicity of infection of the adenoviral vector. The choice of the transgene promoter influenced the level of ecotropic receptor expression by CD34 + cells transduced with adenoviral + cells were only exposed to ecotropic retrovirus MGirL22Y. Although results show total number of colonies, both myeloid and erythroid colonies were conferred resistance to trimetrexate and the proportion of these respective colonies was similar to that observed with mock-transduced, non-drug-treated plates. Similar results were obtained following sequential transduction of CD34 + from two other cord blood samples. 
Figure 7 Sequential transduction of the CD34

or mock transduced (top panel). The cells were then exposed to MGirL22Y ecotropic retrovirus at an MOI of 5. Ecotropic receptor expression as a marker of adenoviral transduction (a) and GFP expression (b) resulting from the transduction with the ecotropic virus were determined by flow cytometry.
vectors encoding the ecotropic receptor. A chimeric adenoviral vector in which a portion of the fiber-coding sequences has been replaced with a corresponding segment of the fiber-coding sequences from an Ad3 serotype transduced hematopoietic cells substantially more efficiently than conventional Ad5 vectors. Our work has been done with human cord blood cells although others have shown that adult human hematopoietic cells may be transduced efficiently with adenoviral vectors. [20] [21] [22] [23] These results indicate that receptor density is a quantitatively important determinant of retroviral transduction efficiency of hematopoietic cells. Similar results have recently been reported in studies of several epithelial cell lines. 19 The direct correlation between receptor level and transduction efficiency was also observed by Orlic and coworkers 10 in their comparison of gene transfer into a single stem cell population using an equal mixture of ecotropic and amphotropic vector preparations of equivalent titer. Transduction with the ecotropic vector was more efficient and correlated with the level of expression of its receptor compared with the amphotropic vector. The ability to increase transduction efficiency with amphotropic vectors by culture of cells in low phosphate medium, thereby increasing expression of the phosphate symporter which functions as the amphotropic receptor, 32 provides further support for the hypothesis that receptor number and transduction efficiency are directly correlated within the physiological range of receptor expression. Thus, successful use of the sequential vector strategy to gain stable integration of the retroviral genome into a target population requires optimization of adenovirus-mediated retroviral receptor expression.
Adenoviruses enter cells through interaction of the capsid fiber protein with a cell surface protein which acts as a binding receptor and by interaction of the penton base with an integrin which facilitates internalization of the adenoviral particle. 33, 34 Viruses of the Ad5 serotype (group C) from which most gene transfer vectors have been derived utilize a receptor which is shared with Coxsackie B viruses (CAR). 34 The receptor for the Ad3 serotype (Group B) is unknown. The chimeric adenoviral vector of Ad3 receptor specificity used in our experiments has been shown to transduce many, but not all, cell lines more efficiently than conventional Ad5 vectors. 29 We have now extended these results by showing that human hematopoietic cells are also more efficiently transduced with vectors having the Ad3 receptor specificity. Expression of CAR in primitive, human hematopoietic cells has been demonstrated by the reverse transcriptase-polymerase chain reaction methodology, 23 but our results suggest that the corresponding receptor for vectors of Ad3 receptor specificity either functions more efficiently or is expressed at a higher level. Thus we conclude that efforts to develop the sequential adenoviralretroviral system for gene transfer into stem cells may be best accomplished with vectors of Ad3 receptor specificity. Alternative strategies in which the peptide sequence of a heterologous ligand is inserted into the fiber 35 or penton base 36 in an effort to achieve receptormediated targeting of a vector are also being considered for other cellular targets and, if successful, might be explored for adenovirus-mediated gene transfer into stem cells. Of interest is the fact that the integrins which are thought to serve as co-receptors in facilitating internalization of adenoviral particles are expressed at relatively low levels on hematopoietic cells. 20 Presumably, alternative cell surface molecules can perform this function or the use of high multiplicities of infection overcomes this limitation.
Another factor that was found to limit adenovirusmediated ecotropic receptor expression and consequently ecotropic retroviral transduction was the adenoviral transgene promoter. The RSV promoter used in our adenoviral vectors functions well in HeLa cells but inefficiently in cord blood-derived CD34 + cells. This may explain why it was possible to purge malignant cells from the bone marrow without toxicity to clonogenic progenitor by using an adenovirus containing the Bcl-xs cDNA driven by the RSV promoter. 37 Our study demonstrates that the CMV E1a and MSCV promoters function efficiently in human hematopoietic stem cells; an observation that is consistent with other reports. 20, 23, 31 Indeed, adenoviral vectors in which the ecotropic receptor gene is under the control of the CMV promoter resulted in significantly higher transduction frequencies with a reciprocal increase in the transduction of the CD34 + cells and the clonogenic hematopoietic progenitors with ecotropic retroviral vectors. Thus, the systematic evaluation of various promoter-enhancer combinations in an effort to optimize retroviral receptor expression for genetic modification of stem cells may be a fruitful exercise when utilizing the sequential transduction strategy.
Studies in NOD/SCID 38, 39 mice demonstrate that the reconstituting ability of the CD34 + cell population lies in the CD38 − fraction. Therefore, CD34
+ CD38 − cells are the ideal target population for gene therapy as modification of a small number of these cells could generate sufficient gene-modified progeny to cure or ameliorate many disorders affecting the hematopoietic system. A number of studies have shown that compared with CD34
+ population the CD34 +
CD38
− cells are not transduced to a significant level by retroviral vectors. 39, 40 Our study confirms the previous observation that the CD34 + CD38
− population can be efficiently transduced by adenoviral vectors. 20 In addition, we demonstrate that retroviral transduction of this subset is to an extent limited by receptor expression since higher levels of ecotropic receptor expression by Av9 CMV-EcoRec lead to enhanced retroviral transduction.
Recombinant AAV (rAAV) vectors have also been shown to be capable of expressing an ecotropic retroviral receptor gene in primary hematopoietic cells thereby facilitating transduction of clonogenic progenitors with a retroviral vector. 18 The efficiency of sequential transduction with rAAV and an ecotropic retroviral vector of 7-14% is significantly lower than what we have observed with the combination of adenoviral and retroviral vectors. One advantage of adenoviral vectors is their consistent lack of integration. In contrast, rAAV vectors may integrate their genome potentially leading to unneeded, persistent expression of the ecotropic receptor. 18 Furthermore, in contrast to adenoviral vectors, rAAV vectors transduce non-cycling cells less efficiently than cycling cells. 27 One limitation in the use of adenoviral vectors for gene therapy protocols is their ability to induce an immune response both to adenoviral proteins and to the expressed transgene.
41 Adenoviral vectors efficiently transduce dendritic cells. 23, 42 Expression of a transgene in transduced dendritic cells invokes a cytotoxic T-lymphocyte response leading to destruction of other transgene expressing cells in vivo. 42 The successful application of the sequential adenoviral-retroviral vector transduction system for ex vivo gene transfer into repopulating stem cells is, therefore, likely to depend on strategies that eliminate any transduced dendritic cells from the population of genetically modified cells which is used to achieve hematopoietic reconstitution. Of interest is the new generation of adenoviral vectors, which are completely devoid of all viral protein-coding sequences. These new helper dependent adenoviral vectors have significantly reduced immunogenicity 37, 43 and consequently show great promise for sequential transduction into the hematopoietic stem cells.
Materials and methods
Cell lines
HeLa (human cervical carcinoma), NIH3T3 and K562 (human erythroleukemia) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum, 2 mm glutamine, 100 U/ml of penicillin and 0.1 mg/ml of streptomycin. Human embryonic kidney cells (293) were obtained from the American Type Culture Collection (ATCC CCL-1573) and cultured in DMEM containing 10% fetal calf serum, 2 mm glutamine, 100 U/ml of penicillin and 0.1 mg/ml of streptomycin. KG-1a (human acute myelogenous leukemia) cells (CCL-246.1) were cultured in RPMI-1640 containing 20% fetal calf serum, 4 mm glutamine, 100 U/ml of penicillin and 0.1 mg/ml of streptomycin. All cells were incubated at 37°C in a humidified atmosphere containing 5% CO 2 .
The ecotropic retroviral producer cell line for the vector, G1-NGFR T14 kindly supplied by Dr Dagmar Dilloo (Heinrich Heine University, Dusseldorf, Germany). This vector encodes a truncated form of the nerve growth factor receptor, which lacks the C-terminal internal domain. The producer cell line for the ecotropic retroviral vector MGirL22Y has been described before. 4 This murine stem cell virus-based bicistronic vector contains the green fluorescent protein (GFP) followed by an internal ribosome entry site (IRES) element directing the translation of the L22Y variant of human dihydrofolate reductase (DHFR). Both ecotropic producer cell lines were derived from the GP+E86 packaging cell line (ATCC; CRL-9642) and maintained in DMEM containing 10% fetal calf serum, 2 mm glutamine, 100 U/ml of penicillin and 0.1 mg/ml of streptomycin. Vector containing medium was collected once the producer cells reached confluency, filtered through a 0.45 m pore size filter, divided into aliquots and stored frozen at −80°C until needed. The titers of the G1-NGFR T and the MGirL22Y retroviral stocks was estimated to be 1-5 × 10 5 infectious units/ml as determined by the expression of NGFR T or GFP on NIH3T3 cells transduced with serial dilutions of the respective vector preparation.
Generation of recombinant adenoviral viral vectors encoding the ecotropic retrovirus receptor
The plasmid pAVs6-EcoRec was constructed by ligating the BamHI-EcoRI fragment from pJET, encompassing cDNA encoding the ecotropic receptor (EcoRec), into the EcoRV site of pAVs6 9 after blunting with the Klenow fragment of DNA polymerase. The EcoRV site in pAVs6 is flanked at the 5Ј end by the adenoviral ITR, the Rous sarcoma virus (RSV) promoter and the fused tripartite leader (from hexon mRNA) and on the 3Ј end by the SV40 splice-polyA site and a segment of Ad-5 DNA (nucleotides 3329-6248) which is required for recombination. The plasmid pAd-CMV-EcoRec was made by a three-way ligation between the 3.1 kb SalI-StuI from pCMV-EcoRec, and the 3.6 kb XhoI-EcoRI and the 5. 16 Positive plaques were subjected to two additional rounds of plaque purification with 293 expansion and DNA characterization at each step. Purified recombinant adenoviral vectors were isolated following amplification of the respective viruses on 293 cells and purification by conventional techniques. Ad5 CMV-GFP was a gift from Craig Jordan (University of Kentucky, Lexington, KT, USA). Titers of all vector preparations were determined by plaque formation on 293 cells and the multiplicity of infection (MOI) used in subsequent experiments were based on the infectious titer (p.f.u./ml) on these cells.
Transduction of human cell lines
Transduction with recombinant adenovirus (rAd) was performed by the addition of the various amounts of the vector preparation to 2 × 10 5 target cells in 2 ml of the appropriate media containing 2% fetal calf serum followed by incubation in a 5% CO 2 humidified atmosphere at 37°C for 90 min with periodic rocking. Following the 90-min incubation, 10 ml of the appropriate medium containing 10% fetal calf serum was added and the cells were incubated overnight. The following morning, vector-containing medium was replaced with fresh medium and the cells were incubated at 37°C for an additional 48 h. A proportion of the cells were then assayed for presence of ecotropic receptor on the cell surface by using a virus binding assay. 16 At the same time, 10 5 cells were transduced with the ecotropic retroviral vector, G1-NGFR T , at a MOI of 5 in the presence of polybrene (6 g/ml). After overnight incubation, fresh medium was added and the cells cultured for another 48 h. The expression of NGFR T on the cell surface was assayed as previously described. 16 Following sequential adenoviral and retroviral vector transduction of K562 cells, 200 or 500 cells were plated in semi-solid medium containing methylcellulose (MethoCult H4230, Stem Cell Technology, Vancouver, BC, Canada) and after 14-16 days, individual colonies were picked and expanded in liquid medium.
Transduction of cells with Av1 RSV-LacZ4 and Av9 RSV-LacZ4 was performed as described above but following the 48-h incubation 2 × 10 5 cells were spun on to a slide (500 r.p.m. for 4 min) using a Shandon Cytospin 3 (Pittsburgh, PA, USA). The cells were then fixed to the slide and stained for ␤-galactosidase activity. 44 Isolation of hematopoietic progenitor cells Samples of umbilical cord blood (CB) were obtained from discarded placental and umbilical tissues by drainage of blood into sterile collection bags. Mononuclear cells were isolated by layering the blood on to Ficoll-Hypaque (1.077 g/ml; Sigma, St Louis, MO, USA) and centrifuged at 400 g for 30 min at room temperature. CD34
+ cells were enriched from this population by depletion of cells positive for lineage markers using either the StemSep (Stem Cell Technologies) or the MiniMACs (Myltenyi Biotech, Auburn, CA, USA) magnetic separation kits according to the manufacturer's specifications. The purity of the CD34 + population ranged from 85% to 98% as evaluated by flow cytometry. The CD34 +
CD38
− subset was isolated from purified CD34
+ cells following staining with fluorescein isothiocyanate conjugated mouse anti-human CD34 (FITC) and a mouse anti-human CD38 phycoerythrin (PE) labeled antibody (Becton Dickinson, San Jose, CA, USA). These cells were sterilely sorted for the lowest 5% of CD38 − cells, using a FACS Vantage flow cytometer (Becton Dickinson).
Transduction of hematopoietic progenitor cells
The CD34
+ cells were either transduced with recombinant adenoviral vectors immediately following isolation or following overnight pre-stimulation in DMEM (D 10+C ) supplemented with 10% FBS, interleukin-3 (IL-3; 20 ng/ml), interleukin-6 (IL-6; 50 ng/ml) and stem cell factor (SCF; 50 ng/ml). Typically, 4 × 10 5 CD34 + in 200 l of DMEM containing 2% FBS were incubated with recombinant adenoviral vectors at the indicated multiplicity of infection (MOI) in 48-well polystyrene plates (Corning, New York, NY, USA) in a 5% CO 2 humidified atmosphere at 37°C for 90 min with periodic rocking. Cells were then supplemented with 1 ml of D 10+C until further processing.
Sequential transduction of CD34
+ cells Ad-EcoRec and retrovirus CD34 + cells transduced with adenoviral vectors encoding the EcoRec gene were expanded for 24 h in D 10+C and then exposed three times to conditioned media from either the G1-NGFR T or the MGirL22Y retrovirus producer cells, at a MOI of approximately 5 in the presence of 5 g/ml protamine sulfate. Retroviral transduction with MGirL22Y were performed in 48-well plates coated with the recombinant fibronectin fragment CH-296 (Takara Shuzo, Otsu, Japan) at a concentration of 10 g/cm 2 as described previously, 14 to enhance transduction efficiency.
Flow cytometric analysis of transduced cells
Transduced cells were washed twice in PBS containing 1% serum. Ecotropic receptor expression was assessed using a virus binding assay as described before. 16 To assess expression of NGFR T cells were incubated with an unconjugated mouse antihuman NGFR T antibody (Boehringer Mannheim, Mannheim, Germany) which was detected with a goat antimouse FITC antibody (Becton Dickinson) using an appropriate isotype matched control. Flow cytometric analysis of transduced CD34 + cells was determined with directly conjugated mouse monoclonal antibodies against human CD34 (PerCPlabeled) and human CD38 (APC-conjugated) and appropriate isotype matched control antibodies (Becton Dickinson).
In vitro clonogenic assay Purified CD34
+ cells and cells sequentially transduced with recombinant adenovirus followed by G1-NGFR T retrovirus were plated in methylcellulose semi-solid culture media (Methocult H4230; Stem Cell Technologies) on 35-mm dishes and incubated at 37 o C in a 5% CO 2 humidified atmosphere. DNA was isolated from the erythroid and myeloid hematopoietic colonies according to the method Cassell et al 45 after 10-14 days of culture. CD34
+ cells transduced with MGirL22Y ecotropic virus were plated in methylcellulose (Methocult H4230; Stem Cell Technologies) which had been pretreated with 3 U thymidine phosphorylase (Sigma) at 37°C for 2 h, in the presence or absence of trimetrexate (TMX, 150 nMol/l). Hematopoietic colonies were enumerated at 10-14 days of culture.
DNA isolation and analysis
High molecular weight genomic DNA from the K562 cells was isolated using Puregene (Gentra Systems, Minneapolis, MN, USA). Southern blot analysis was performed by fractionating 12.5 g of digested DNA on 0.8% agarose, followed by transfer to nylon membranes (Hybond N+, Amersham Life Sciences, Arlington Heights, IL, USA) using a turboblotter (Schleicher and Schuell, Keene, NH, USA) and overnight hybridization with the appropriate probe in Hybrisol I (Oncor, Gaithersburg, MD, USA). The retroviral probe used was the 306 bp NotI-PstI fragment from pG1Na 46 while the ecotropic receptor probe was the 476 bp PstI-HpaI fragment from the cDNA. 16 Following hybridization, filters were washed twice with 3 × SSC, 0.5% SDS and twice with 0.5 × SSC, 0.5% SDS for 30 min per wash.
PCR was used to detect the G1-NGFR T proviral genome in DNA from colonies derived from transduced hematopoietic progenitors. The sequence of the primers used was 5Ј ACGGCTACTACCAGGATGAGACGA 3Ј and 5Ј CGTGCTGGCTATGAGGTCTTGTTC 3Ј. The PCR conditions used were 94°C for 4 min followed by 30 cycles of 94°C for 1 min, 60°C for 1 min and 72°C for 1 min and ending with 72°C for 4 min.
